📣 VC round data is live. Check it out!

Clover Health Valuation Multiples

Discover Clover Health's revenue and EBITDA valuation multiples and investment history, alongside public comparables like Progyny, Slide Insurance Holdings, Lancashire Holdings, Stewart Title and more.

Clover Health Overview

About Clover Health

Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.


Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Clover Health Financials

Clover Health reported last 12-month revenue of $2B and EBITDA of $37M.

In the same LTM period, Clover Health generated $37M in EBITDA and had net loss of ($47M).

Revenue (LTM)


Clover Health P&L

In the most recent fiscal year, Clover Health reported revenue of $2B and EBITDA of $22M.

Clover Health is unprofitable as of last fiscal year, with gross margin of 18%, EBITDA margin of 1%, and net margin of (4%).

See analyst estimates for Clover Health
LTMLast FY202320242025202620272028
Revenue$2B$2B$2B$1B$2B
Gross Profit-$356M$257M$365M$356M
Gross Margin-18%13%27%18%
EBITDA$37M$22M($211M)($45M)($84M)
EBITDA Margin2%1%(10%)(3%)(4%)
EBIT Margin(2%)(4%)(9%)(3%)(4%)
Net Profit($47M)($86M)($213M)($43M)($86M)
Net Margin(2%)(4%)(10%)(3%)(4%)

Financial data powered by Morningstar, Inc.

Clover Health Stock Performance

Clover Health has current market cap of $2B, and enterprise value of $2B.

Market Cap Evolution


Clover Health's stock price is $3.92.

Clover Health share price decreased by 1.8% in the last 30 days, and increased by 40.5% in the last year.

Clover Health has an EPS (earnings per share) of $-0.16.

See more trading valuation data for Clover Health
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$2B$2B-1.8%-1.8%122.7%40.5%$-0.16

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Clover Health Valuation Multiples

Clover Health trades at 0.7x EV/Revenue multiple, and 47.2x EV/EBITDA.

See NTM and 2027E valuation multiples for Clover Health

EV / Revenue (LTM)


Clover Health Financial Valuation Multiples

As of June 2, 2026, Clover Health has market cap of $2B and EV of $2B.

Clover Health has a P/E ratio of (43.9x).

LTMLast FY202320242025202620272028
EV/Revenue0.7x0.9x0.9x1.3x0.9x
EV/EBITDA47.2x80.0x(8.2x)(38.6x)(20.7x)
EV/EBIT(37.9x)(20.8x)(9.5x)(38.2x)(20.3x)
EV/Gross Profit-4.9x6.7x4.8x4.9x
P/E(43.9x)(24.1x)(9.7x)(48.0x)(24.1x)
EV/FCF-(25.2x)(14.9x)52.1x(25.2x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Clover Health Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Clover Health Margins & Growth Rates

Clover Health grew revenue by 51% and EBITDA by 166% in the last fiscal year.

In the most recent fiscal year, Clover Health reported gross margin of 18%, EBITDA margin of 1%, and net margin of (4%).

See estimated margins and future growth rates for Clover Health

Clover Health Margins

Last FY202420252026202720282029
Gross Margin18%27%18%-
EBITDA Margin1%(3%)(4%)2%
EBIT Margin(4%)(3%)(4%)0%
Net Margin(4%)(3%)(4%)0%
FCF Margin(4%)2%(4%)2%

Clover Health Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth51%(33%)40%51%
Gross Profit Growth-42%(2%)-
EBITDA Growth166%(79%)87%(169%)
EBIT Growth(108%)(75%)88%(108%)
Net Profit Growth(108%)(80%)99%(108%)
FCF Growth(177%)(129%)(307%)(177%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Clover Health Operational KPIs

Clover Health's revenue per employee in the last FY averaged $3.4M, while opex per employee averaged $0.8M for the same period.

Clover Health's Rule of 40 is 53% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Clover Health's Rule of X is 130% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Clover Health
LTMLast FY202320242025202620272028
Rule of 4033%53%---
Bessemer Rule of X81%130%---
Revenue per Employee-$3.4M---
Opex per Employee-$0.8M---
G&A Expenses to Revenue10%23%22%30%23%
Opex to Revenue-23%22%30%23%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Progyny1.4x1.4x8.3x8.1x
Slide Insurance Holdings0.5x0.5x1.5x1.5x
Lancashire Holdings1.0x---
Stewart Title0.8x0.8x--
HCI Group1.1x1.1x--
Pluxee(0.7x)(0.7x)(1.8x)(1.8x)
BaoViet0.9x1.1x--
Wafa Assurance SA1.0x1.0x--

This data is available for Pro users. Sign up to see all Clover Health competitors and their valuation data.

Start Free Trial

Clover Health VC Funding History

Before going public, Clover Health raised $925M in total equity funding, across 5 rounds.

Last private valuation of Clover Health was $1B, after raising $130M in May 2017 from DNA Capital, Expanding Capital, Greenoaks, and 9 other investors.


Clover Health Funding Rounds

DateStageRaised FromRaisedValuationRev. MultipleDeal Summary
Jan-19Series EGreenoaks$500M-Clover Health, a San Francisco-based InsurTech providing Medicare Advantage plans, raised $500 million in a Series E funding round on January 29, 2019, led by existing investor Greenoaks Capital, bringing total funding to approximately $925-938 million. The round aimed to scale Medicare Advantage membership, operations, enter new markets thoughtfully, deepen physician ties, and improve care quality through its technology platform that analyzes health and behavioral data for better outcomes, featuring low premiums, co-pays, and out-of-pocket caps. The company, founded in 2012 by Vivek Garipalli and Kris Gale, had faced challenges including growing net losses from $4.9 million in 2015 to $34.6 million in 2016, with 20,600 Medicare Advantage members generating $184 million in taxpayer revenue that year, expanding modestly to 27,000 by September 2017. By the 2019 round, Clover reported 35 percent membership growth over the past year and machine learning models with 85 percent accuracy in predicting hospitalization risk within 28 days; it also launched in-home primary care for high-risk members informed by genomic testing. As part of the financing, CTO Andrew Toy was promoted to president, CTO, and board member. Backed by investors including Alphabet’s GV, Sequoia Capital, Floodgate, Bracket Capital, and First Round Capital, Clover competed in the hot Medicare Advantage space against rivals like Devoted Health and Bright Health, pursuing narrow provider networks and strong data infrastructure. Greenoaks had previously led the $160 million Series C in 2016. The company later went public and raised additional post-IPO equity in 2021.
May-17Series DDNA Capital; Expanding Capital; Greenoaks; GV; Lifeforce Capital; Nelson Chu; Nexus Venture Partners; Palm Drive Capital; Refactor; Vast Ventures; Veronorte; Western Technology Investment$130M$1BClover Health is a San Francisco-based Medicare Advantage insurance provider founded in 2012 by Vivek Garipalli and Kris Gale, using predictive analytics and data science to identify high-risk patients, improve outcomes, and align incentives between doctors and insurers. The company focuses on technology-driven health plans for seniors, initially operating in New Jersey before expanding to states like Georgia, Texas, and Pennsylvania. It competes with larger players like UnitedHealth Group, Humana, Aetna, and Anthem in the Medicare Advantage market, which served over 18 million members with $170 billion in capitated revenue in 2015. In May 2017, Clover Health raised $130 million in a funding round led by Greenoaks Capital, with participation from GV (Alphabet's venture arm), DNA Capital, Expanding Capital, Nexus Venture Partners, Refactor Capital, Palm Drive Capital, Vast Ventures, Veronorte, Western Technology Investment, Lifeforce Capital, and Nelson Chu, among others, bringing total funding to $425 million. The post-money valuation reached approximately $1.2 billion, establishing it as a unicorn. The funds supported measured expansion and technology enhancements rather than rapid scaling. At the time of the round, Clover had around 25,000 to 27,000 Medicare Advantage members, up from 20,600 in 2016 and 16,700 in May 2016. Revenue grew to $267 million in 2017 from $184 million in 2016, driven by membership increases, though the company remained unprofitable with a net loss of $22 million in 2017, improved from $34.6 million in 2016 and $4.9 million in 2015. It faced challenges including a CMS fine of nearly $110,000 for misleading marketing, delayed lab payments, and a star rating drop from 3.5 to 3. Post-round, Clover promoted internal leadership changes, with Andrew Toy becoming president and CTO in 2018, while co-founder Kris Gale transitioned to an adviser. The company continued attracting investor interest, raising additional rounds like $500 million in 2019 led by Greenoaks, but struggled with projections for membership doubling and profitability.
May-16Series CGreenoaks$160M-Clover Health is a San Francisco-based health insurance startup founded in 2012, specializing in Medicare Advantage plans that leverage data-driven analytics and patient-centered care management to identify risks and provide preventive care. The company's model offers out-of-network benefits, zero monthly premiums, copayments, and generic prescriptions, initially available in select New Jersey counties like Jersey City. In May 2016, Clover Health raised $160 million in a Series C funding round led by Greenoaks Capital, with participation from existing investors including Arena Ventures, First Round Capital, Sequoia Capital, Social Capital, and Wildcat Ventures, plus new investors AME Cloud Ventures, Casdin Capital, Floodgate, Nexus Ventures, Refactor Capital, and Spark Capital. This brought total funding to $285 million. The round aimed to expand market reach and improve service offerings, with the company serving around 25,000 customers in New Jersey at the time and planning measured growth to additional states. Around 2016, Clover Health had approximately 20,000 Medicare Advantage members, growing to 27,000 by September 2017, earning roughly $10,000 per member from CMS, though not explicitly termed revenue for that period. The company faced challenges including a federal fine for marketing inaccuracies and reported a $34.6 million loss in 2016. Later rounds included a $500 million Series E in January 2019 led by Greenoaks and a $400 million post-IPO raise in 2021.
Dec-15Series BAthyrium Capital Management LP; Bracket Capital; First Round Capital; Outlander Fund I Archimedes; Sequoia Capital; Wildcat Venture Partners$35M-Clover Health is a Medicare Advantage health insurance provider founded in 2012 that uses technology, data analytics, and care management to identify high-risk patients, reduce hospital admissions, and improve health outcomes while lowering costs. The company offers members benefits like $0 monthly premiums, $0 co-pays for primary care, $0 generic prescriptions, and enhanced out-of-network coverage. In December 2015, Clover Health raised $35 million in a Series B round led by Sequoia Capital, with participation from existing investors First Round Capital, Athyrium Capital Management, and others including Bracket Capital and Wildcat Venture Partners. The funds were intended to scale engineering, data science, and care management teams, drive growth and innovation, and expand into new markets. This Series B followed a September 2015 round of $100 million (a mix of debt and venture financing led by First Round Capital). In 2015, the company generated $184 million in revenue from 20,600 Medicare Advantage members, earning approximately $10,000 per member from the Centers for Medicare and Medicaid Services, though it posted a net loss of $4.9 million that year. Clover Health competed in the Medicare Advantage space by leveraging patient-centered analytics to bend the risk curve and provide preventive care. Membership grew modestly from 20,000 in 2016 to 27,000 by September 2017, with losses increasing to $34.6 million in 2016. The company later raised additional rounds, including a $130 million Series D in 2017 at a $1.2 billion valuation, a $500 million round in 2019 led by Greenoaks Capital, and went public via SPAC in 2021.
Sep-15Series AAthyrium Capital Management LP; First Round Capital$100M-Clover Health is an American healthcare company founded in 2014 by Kris Gale and Vivek Garipalli that focuses on Medicare Advantage insurance plans for seniors and disabled individuals. The company uses data analysis and preventive care to identify high-risk patients and intervenes through a team of nurse practitioners and social workers to reduce hospitalizations and costs. In September 2015, Clover Health raised $100 million in a Series A financing round led by First Round Capital, with Athyrium Capital Management also participating. This was First Round Capital's largest investment ever, representing an exception to the firm's typical seed-stage focus, and the round reflected the company's demonstrable traction and scale after two years of operations. The company competed against larger Medicare health insurance providers like United and Cigna by leveraging technology and data science to create a more targeted approach to managing patient health. Shortly after the Series A close in December 2015, the company raised an additional $35 million Series B round led by Sequoia Capital, demonstrating strong investor momentum and confidence in the business model.

Investments by Clover Health

Clover Health has invested in 1 company to date.

Latest investment by Clover Health was on December 10th 2019. Clover Health invested in Wagmo in their $3M Seed round (EV/Revenue multiple available to Pro users).

See VC round multiples

Latest Investments by Clover Health

Wagmo
Description
Wagmo is a pet wellness platform combining insurance with routine care reimbursements for exams, vaccines, flea prevention, and dental cleanings using veterinary billing data. New York-based and founded in 2019, it covers dogs and cats up to $25,000 annually with no exam fees required, partnering with 10,000+ vets nationwide. Wagmo serves 50,000+ pets, offering app-based claims processing under 24 hours.
HQ CountryUnited States
HQ City
New York City, NY
Deal Date10 Dec 2019
RoundSeed
Raised$3M
InvestorsClocktower Technology Ventures; Clover Health; David Olk; Everywhere Ventures; Female Founders Fund; Flatiron Health; Harlem Capital; K50 Ventures; Kli Capital; Vestigo Ventures
Valuationundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Clover Health investments and their VC round multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Clover Health

When was Clover Health founded?Clover Health was founded in 2019.
Where is Clover Health headquartered?Clover Health is headquartered in United States.
How many employees does Clover Health have?As of today, Clover Health has over 570 employees.
Who is the CEO of Clover Health?Clover Health's CEO is Andrew Toy.
Is Clover Health publicly listed?Yes, Clover Health is a public company listed on Nasdaq.
What is the stock symbol of Clover Health?Clover Health trades under CLOV ticker.
When did Clover Health go public?Clover Health went public in 2021.
Who are competitors of Clover Health?Clover Health main competitors include Progyny, Slide Insurance Holdings, Lancashire Holdings, Stewart Title, HCI Group, Pluxee, BaoViet, Wafa Assurance SA, nib Group, Allianz-Slovenska.
What is the current market cap of Clover Health?Clover Health's current market cap is $2B.
What is the current revenue of Clover Health?Clover Health's last 12 months revenue is $2B.
What is the current revenue growth of Clover Health?Clover Health revenue growth (NTM/LTM) is 32%.
What is the current EV/Revenue multiple of Clover Health?Current revenue multiple of Clover Health is 0.7x.
What is the current EBITDA of Clover Health?Clover Health's last 12 months EBITDA is $37M.
What is Clover Health's EBITDA margin?Clover Health's last 12 months EBITDA margin is 2%.
What is the current EV/EBITDA multiple of Clover Health?Current EBITDA multiple of Clover Health is 47.2x.
How many companies Clover Health has acquired to date?Clover Health hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Clover Health has invested to date?As of June 2026, Clover Health has invested in 1 company.
What was the last Clover Health investment?On 10th December 2019 Clover Health invested in Wagmo, participating in a $3M Seed round, alongside Clocktower Technology Ventures, David Olk, Everywhere Ventures, Female Founders Fund, Flatiron Health, Harlem Capital, K50 Ventures, Kli Capital, and Vestigo Ventures.
In what companies Clover Health invested in?Clover Health invested in Wagmo.

See public comps similar to Clover Health

Lists including Clover Health

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial